Follow
Jianfeng Guo
Jianfeng Guo
School of Pharmaceutical Sciences, Jilin University
Verified email at jlu.edu.cn
Title
Cited by
Cited by
Year
Gold nanoparticles enlighten the future of cancer theranostics
J Guo, K Rahme, Y He, LL Li, JD Holmes, CM O’Driscoll
International journal of nanomedicine, 6131-6152, 2017
2802017
Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma
Z Yu, J Guo, M Hu, Y Gao, L Huang
Acs Nano 14 (4), 4816-4828, 2020
2082020
Nano codelivery of oxaliplatin and folinic acid achieves synergistic chemo-immunotherapy with 5-fluorouracil for colorectal cancer and liver metastasis
J Guo, Z Yu, M Das, L Huang
ACS nano 14 (4), 5075-5089, 2020
1482020
Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?
J Guo, L Bourre, DM Soden, GC O'Sullivan, C O'Driscoll
Biotechnology advances 29 (4), 402-417, 2011
1462011
Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice
J Guo, JR Ogier, S Desgranges, R Darcy, C O’Driscoll
Biomaterials 33 (31), 7775-7784, 2012
1362012
Therapeutic targeting in the silent era: advances in non-viral siRNA delivery
J Guo, KA Fisher, R Darcy, JF Cryan, C O’Driscoll
Molecular Biosystems 6 (7), 1143-1161, 2010
1342010
The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics
KA Fitzgerald, J Guo, EG Tierney, CM Curtin, M Malhotra, R Darcy, ...
Biomaterials 66, 53-66, 2015
1172015
Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice
J Guo, WP Cheng, J Gu, C Ding, X Qu, Z Yang, C O’Driscoll
European Journal of Pharmaceutical Sciences 45 (5), 521-532, 2012
992012
Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs
BT Griffin, J Guo, E Presas, MD Donovan, MJ Alonso, CM O'Driscoll
Advanced Drug Delivery Reviews 106, 367-380, 2016
932016
Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells
J Guo, CM O’Driscoll, JD Holmes, K Rahme
International journal of pharmaceutics 509 (1-2), 16-27, 2016
802016
Mechanistic studies on the uptake and intracellular trafficking of novel cyclodextrin transfection complexes by intestinal epithelial cells
MJ O’Neill, J Guo, C Byrne, R Darcy, CM O’Driscoll
International journal of pharmaceutics 413 (1-2), 174-183, 2011
802011
Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
Y Liu, J Guo, L Huang
Theranostics 10 (7), 3099-3117, 2020
782020
Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma
J Guo, Z Yu, D Sun, Y Zou, Y Liu, L Huang
Molecular Cancer 20, 1-17, 2021
752021
A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer
D Sun, Y Zou, L Song, S Han, H Yang, D Chu, Y Dai, J Ma, CM O'Driscoll, ...
Acta Pharmaceutica Sinica B 12 (1), 378-393, 2022
722022
Tackling TAMs for cancer immunotherapy: it’s nano time
Y Yang, J Guo, L Huang
Trends in pharmacological sciences 41 (10), 701-714, 2020
642020
Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic …
J Guo, EG Russell, R Darcy, TG Cotter, SL McKenna, MR Cahill, ...
Molecular pharmaceutics 14 (3), 940-952, 2017
602017
A low molecular weight hyaluronic acid derivative accelerates excisional wound healing by modulating pro-inflammation, promoting epithelialization and neovascularization, and …
Y Gao, Y Sun, H Yang, P Qiu, Z Cong, Y Zou, L Song, J Guo, ...
International journal of molecular sciences 20 (15), 3722, 2019
582019
Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer–synthesis, physicochemical characterisation and in vitro evaluation
KA Fitzgerald, K Rahme, J Guo, JD Holmes, CM O'Driscoll
Journal of materials chemistry B 4 (13), 2242-2252, 2016
542016
Membrane-core nanoparticles for cancer nanomedicine
J Guo, L Huang
Advanced drug delivery reviews 156, 23-39, 2020
512020
Folate-targeted amphiphilic cyclodextrin. siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged …
JC Evans, M Malhotra, J Guo, JP O'Shea, K Hanrahan, A O'Neill, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (8), 2341-2351, 2016
512016
The system can't perform the operation now. Try again later.
Articles 1–20